Repligen Corporation has launched three new high-performance chromatography resins, AVIPure® HiPer™ AAV9, AVIPure® HiPer™ AAV8, and HiPer™ QA anion exchange resin. These new solutions are designed to help gene therapy developers accelerate product development and improve process economics. The resins are built on Tantti™ DuloCore™ base bead technology and are aimed at enhancing molecule stability for viral vectors. Repligen remains committed to providing cutting-edge tools for customers and anticipates broader chromatography resin launches in 2026. The company’s focus on innovation in bioprocessing technologies continues to drive progress in the industry.

Read more at GlobeNewswire: Repligen Introduces Next-Generation Chromatography Resins